Javascript must be enabled to continue!
Relationship between thyroid function and ICU mortality: a prospective observation study
View through CrossRef
Abstract
Introduction
Although nonthyroidal illness syndrome is considered to be associated with adverse outcome in ICU patients, the performance of thyroid hormone levels in predicting clinical outcome in ICU patients is unimpressive. This study was conducted to assess the prognostic value of the complete thyroid indicators (free triiodothyronine (FT3), total triiodothyronine; free thyroxine, total thyroxine, thyroid-stimulating hormone and reverse triiodothyronine) in unselected ICU patients.
Methods
A total of 480 consecutive patients without known thyroid diseases were screened for eligibility and followed up during their ICU stay. We collected each patient's baseline characteristics, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) score and thyroid hormone, N-terminal pro-brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) levels. The primary outcome was ICU mortality. Potential predictors were analyzed for possible association with outcomes. We also evaluated the ability of thyroid hormones together with APACHE II score to predict ICU mortality by calculation of net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices.
Results
Among the thyroid hormone indicators, FT3 had the greatest power to predict ICU mortality, as suggested by the largest area under the curve (AUC) of 0.762 ± 0.028. The AUC for FT3 level was less than that for APACHE II score (0.829 ± 0.022) but greater than that for NT-proBNP level (0.724 ± 0.030) or CRP level (0.689 ± 0.030). Multiple regression analysis revealed that FT3 level (standardized β = -0.600, P = 0.001), APACHE II score (standardized β = 0.912, P < 0.001), NT-proBNP level (standardized β = 0.459, P = 0.017) and CRP level (standardized β = 0.367, P = 0.030) could independently predict primary outcome. The addition of FT3 level to APACHE II score gave an NRI of 54.29% (P < 0.001) and an IDI of 36.54% (P < 0.001). The level of FT3 was significantly correlated with NT-proBNP levels (r = -0.344, P < 0.001) and CRP levels (r = -0.408, P < 0.001).
Conclusion
In unselected ICU patients, FT3 was the most powerful and only independent predictor of ICU mortality among the complete indicators. The addition of FT3 level to the APACHE II score could significantly improve the ability to predict ICU mortality.
Springer Science and Business Media LLC
Title: Relationship between thyroid function and ICU mortality: a prospective observation study
Description:
Abstract
Introduction
Although nonthyroidal illness syndrome is considered to be associated with adverse outcome in ICU patients, the performance of thyroid hormone levels in predicting clinical outcome in ICU patients is unimpressive.
This study was conducted to assess the prognostic value of the complete thyroid indicators (free triiodothyronine (FT3), total triiodothyronine; free thyroxine, total thyroxine, thyroid-stimulating hormone and reverse triiodothyronine) in unselected ICU patients.
Methods
A total of 480 consecutive patients without known thyroid diseases were screened for eligibility and followed up during their ICU stay.
We collected each patient's baseline characteristics, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) score and thyroid hormone, N-terminal pro-brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) levels.
The primary outcome was ICU mortality.
Potential predictors were analyzed for possible association with outcomes.
We also evaluated the ability of thyroid hormones together with APACHE II score to predict ICU mortality by calculation of net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices.
Results
Among the thyroid hormone indicators, FT3 had the greatest power to predict ICU mortality, as suggested by the largest area under the curve (AUC) of 0.
762 ± 0.
028.
The AUC for FT3 level was less than that for APACHE II score (0.
829 ± 0.
022) but greater than that for NT-proBNP level (0.
724 ± 0.
030) or CRP level (0.
689 ± 0.
030).
Multiple regression analysis revealed that FT3 level (standardized β = -0.
600, P = 0.
001), APACHE II score (standardized β = 0.
912, P < 0.
001), NT-proBNP level (standardized β = 0.
459, P = 0.
017) and CRP level (standardized β = 0.
367, P = 0.
030) could independently predict primary outcome.
The addition of FT3 level to APACHE II score gave an NRI of 54.
29% (P < 0.
001) and an IDI of 36.
54% (P < 0.
001).
The level of FT3 was significantly correlated with NT-proBNP levels (r = -0.
344, P < 0.
001) and CRP levels (r = -0.
408, P < 0.
001).
Conclusion
In unselected ICU patients, FT3 was the most powerful and only independent predictor of ICU mortality among the complete indicators.
The addition of FT3 level to the APACHE II score could significantly improve the ability to predict ICU mortality.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
Abstract
Introduction
The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (...
Relationship between serum NDRG3 and papillary thyroid carcinoma
Relationship between serum NDRG3 and papillary thyroid carcinoma
BackgroundIn recent years, papillary thyroid carcinoma is considered to be one of the fastest increaseing cancer. NDRG family member 3 (NDRG3) has been proposed as a molecular mark...
Molecular prognostication of thyroid tumors : with special focus on TERT
Molecular prognostication of thyroid tumors : with special focus on TERT
<p dir="ltr">Thyroid carcinoma is the most common endocrine malignancy, with its incidence steadily increasing worldwide. These tumors can be challenging to diagnose, and tre...
Molecular prognostication of thyroid tumors : with special focus on TERT
Molecular prognostication of thyroid tumors : with special focus on TERT
<p dir="ltr">Thyroid carcinoma is the most common endocrine malignancy, with its incidence steadily increasing worldwide. These tumors can be challenging to diagnose, and tre...
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Abstract
Introduction
Kikuchi-Fujimoto Disease (KFD), characterized by histiocytic necrotizing lymphadenitis, is a rare condition of unknown etiology. Diagnosis is dependent on lym...
In‐ICU Outcomes of Critically Ill Patients in a Reference Cameroonian Intensive Care Unit: A Retrospective Cohort Study
In‐ICU Outcomes of Critically Ill Patients in a Reference Cameroonian Intensive Care Unit: A Retrospective Cohort Study
Introduction. Mortality rate amongst critically ill patients admitted to the intensive care unit (ICU) is disproportionately high in sub‐Saharan African countries such as Cameroon....

